Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app help doctors spot dangerous colon polyps?

NCT ID NCT07424391

Knowledge-focused Sponsor: Clinique Paris-Bercy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a digital training program called Colo-ID helps doctors better predict the type of colon polyps they see during a colonoscopy. About 1,500 adults with at least one polyp will take part. Doctors will record their predictions before and after training, and compare them to lab results. The goal is to see if training improves accuracy, which could lead to fewer unnecessary polyp removals and lower costs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital Training Program (Colo-ID)
What this could lead to
If successful, this could show that a simple digital tool helps doctors make more accurate decisions during colonoscopy, potentially reducing unnecessary polyp removals and lab costs.
What could go wrong
This is an observational study, not a treatment trial. The training is for doctors, not patients, so any benefit is indirect. Results may not apply to other hospitals or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients undergoing colonoscopy in routine clinical practice at Clinique Paris-Bercy, in whom at least one colorectal polyp is detected and optically characterized by participating endoscopists. The study evaluates optical histology prediction performance before and after implementation of the Colo-ID digital training program. Histopathological analysis of resected polyps serves as the reference standard when applicable.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years * Patients undergoing colonoscopy in routine clinical practice at the participating center * At least one colorectal polyp detected during colonoscopy * Optical histology prediction recorded during the procedure * Histopathological analysis available for resected polyps (reference standard) Exclusion Criteria: * Patients aged \<18 years * Refusal/opposition to use of data (if applicable under local regulations) * Missing key study data (e.g., no recorded optical prediction or no histopathology result)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal polyps are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal adenoma polyp of large intestine

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal polyps

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinique Paris-Bercy

    RECRUITING

    Charenton-le-Pont, Val de Marne, 94220, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.